Federal award
AUSTIN NUCLEAR PHARMACY SERVICES LLC
W81K0021P0207
Contract
Obligated and Ceiling
- Obligated (net)
- $343,300.20
- Ceiling (potential value, not spending)
- $373,371.45
- Current value
- $373,371.45
- Gross positive obligations
- $1,240,132.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- AUSTIN NUCLEAR PHARMACY SERVICES LLC · XXNZCY4XT3X5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- AUSTIN NUCLEAR PHARMACY SERVICES LLC · XXNZCY4XT3X5
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81K0021P0207
- Award type code
- B
- Actions
- 21 · Jul 29, 2021 to May 5, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History21
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 5, 2025 | FY2025 | P00020 | C | −$158,310.25 | — |
| Feb 25, 2025 | FY2025 | P00019 | C | −$30,071.25 | — |
| Oct 30, 2024 | FY2025 | P00018 | C | $271,389.00 | — |
| May 7, 2024 | FY2024 | P00017 | C | −$160,405.00 | — |
| Dec 27, 2023 | FY2024 | P00016 | C | −$102,826.00 | — |
| Dec 6, 2023 | FY2024 | P00015 | G | $0.00 | — |
| Oct 13, 2023 | FY2024 | P00014 | C | $271,389.00 | — |
| Aug 11, 2023 | FY2023 | P00013 | C | −$38,055.00 | — |
| Jun 18, 2023 | FY2023 | P00012 | C | −$67,646.00 | — |
| Feb 14, 2023 | FY2023 | P00011 | G | $0.00 | — |
| Oct 27, 2022 | FY2023 | P00010 | C | −$90,724.80 | — |
| Oct 27, 2022 | FY2023 | P00009 | C | $271,389.00 | — |
| Jul 26, 2022 | FY2022 | P00008 | C | −$138,192.50 | — |
| Mar 10, 2022 | FY2022 | P00007 | G | $0.00 | — |
| Feb 10, 2022 | FY2022 | P00006 | B | −$110,601.00 | — |
| Oct 14, 2021 | FY2022 | P00005 | C | $425,965.00 | — |
| Oct 13, 2021 | FY2022 | P00004 | M | $0.00 | — |
| Oct 5, 2021 | FY2022 | P00003 | M | $0.00 | — |
| Sep 20, 2021 | FY2021 | P00002 | M | $0.00 | — |
| Aug 9, 2021 | FY2021 | P00001 | M | $0.00 | — |
| Jul 29, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.